Company Ildong Pharmaceutical Co., Ltd.

Equities

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
13,940 ^KRW	+0.94%		+5.53%	-23.24%

May. 22	Dong-A ST to Become Second-Largest Shareholder of Idience in KRW25 Billion Deal	MT
2023	Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea	MT

IL DONG PHARMACEUTICAL CO., LTD. is a Korea-based company mainly engaged in the manufacture of pharmaceuticals.

Number of employees: 1,007

KRW in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 100.0 %	637,714	100.0 %	600,758	100.0 %	-5.80%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 98.3 %	623,119	97.7 %	590,690	98.3 %	-5.20%
Other 1.0 %	5,054	0.8 %	6,293	1.0 %	+24.51%
Japan 0.6 %	8,864	1.4 %	3,775	0.6 %	-57.42%

Managers	Title	Age	Since
Woong-Sub Yoon CEO	Chief Executive Officer	57	16-08-02
Gyu-Seong Kang DFI	Director of Finance/CFO	58	-
Jin-Shik Seo COO	Chief Operating Officer	54	-
Jeong-Seob Park AUD	Comptroller/Controller/Auditor	53	-
Sang-Yun Lee AUD	Comptroller/Controller/Auditor	67	-

Members of the board	Title	Age	Since
Woong-Sub Yoon CEO	Chief Executive Officer	57	16-08-02
Chang-Rok Seo BRD	Director/Board Member	63	-
Gyu-Seong Kang DFI	Director of Finance/CFO	58	-
Nam-Jong Baek BRD	Director/Board Member	58	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	28,062,501	17,023,694 ( 60.66 %)	130,125 ( 0.4637 %)	60.66 %

Name	Equities	%	Valuation
ILDONG HOLDINGS CO., LTD. 34.41 %	9,656,143	34.41 %	91 M ₩
Won-Young Yoon 2.219 %	622,603	2.219 %	6 M ₩
Yong-ja Jeon 1.448 %	406,384	1.448 %	4 M ₩
Woong-Sub Yoon 1.379 %	386,925	1.379 %	4 M ₩
Songpa Foundation 0.3429 %	96,213	0.3429 %	908 659 ₩
Kyung-ja Lim 0.2060 %	57,800	0.2060 %	545 877 ₩
Hye-jin Yoon 0.1902 %	53,380	0.1902 %	504 134 ₩

Ildong Pharmaceutical Co., Ltd.

2 Baumoe-ro 27-gil Seocho-gu

06752, Seoul

Trading Rating

Investor Rating

ESG Refinitiv

	1st Jan change	Capi.
ILDONG PHARMACEUTICAL CO., LTD.	-23.24%	283M
ELI LILLY AND COMPANY	+62.66%	854B
NOVO NORDISK A/S	+40.42%	636B
JOHNSON & JOHNSON	-4.37%	361B
MERCK & CO., INC.	+17.16%	324B
ABBVIE INC.	+9.87%	301B
ASTRAZENECA PLC	+15.66%	247B
ROCHE HOLDING AG	+4.21%	230B
NOVARTIS AG	+17.90%	228B
AMGEN INC.	+14.86%	177B